Literature DB >> 13678830

Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus.

Glenn W Kaatz1, Varsha V Moudgal, Susan M Seo, John Bondo Hansen, Jette E Kristiansen.   

Abstract

Structural variants of phenylpiperidine selective serotonin reuptake inhibitors (P-SSRIs) inhibited the function of two unique Staphylococcus aureus multidrug efflux pumps. The most active compound was the paroxetine isomer NNC 20-7052, which had an IC(50) for ethidium, acriflavine, and pyronin Y efflux of 9, 53, and 18% of its MIC, respectively, against the NorA pump. The unbalanced effect of NNC 20-7052 on the efflux of different substrates suggests the possibility that P-SSRIs function by a physical interaction with NorA. Under the conditions employed pump inhibition partially extended to the resistance-nodulation-division (RND) pump AcrAB-TolC, but not to the Pseudomonas aeruginosa RND pumps MexAB-OprM or MexCD-OprJ.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678830     DOI: 10.1016/s0924-8579(03)00220-6

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

Review 1.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

2.  Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.

Authors:  Céline Vidaillac; Jean Guillon; Corinne Arpin; Isabelle Forfar-Bares; Boubakar B Ba; Jean Grellet; Stéphane Moreau; Daniel-Henri Caignard; Christian Jarry; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

3.  Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump.

Authors:  Bryan D Schindler; Diixa Patel; Susan M Seo; Glenn W Kaatz
Journal:  J Bacteriol       Date:  2012-11-21       Impact factor: 3.490

Review 4.  The potential action of SSRIs in the treatment of skin diseases including atopic dermatitis and slow-healing wounds.

Authors:  Aneta Kiecka; Marian Szczepanik
Journal:  Pharmacol Rep       Date:  2022-10-07       Impact factor: 3.919

5.  Efflux pump-mediated resistance in chemotherapy.

Authors:  Po Ughachukwu; Pc Unekwe
Journal:  Ann Med Health Sci Res       Date:  2012-07

6.  Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance.

Authors:  Muhammad Ayaz; Fazal Subhan; Jawad Ahmed; Arif-Ullah Khan; Farhat Ullah; Ihsan Ullah; Gowhar Ali; Nawazish-I-Husain Syed; Sajid Hussain
Journal:  J Biol Res (Thessalon)       Date:  2015-04-16       Impact factor: 1.889

7.  Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.

Authors:  Sanath Kumar; Mun Mun Mukherjee; Manuel F Varela
Journal:  Int J Bacteriol       Date:  2013

Review 8.  Efflux pump inhibitors for bacterial pathogens: From bench to bedside.

Authors:  Atin Sharma; Vivek Kumar Gupta; Ranjana Pathania
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

Review 9.  Antibiotic resistance breakers: current approaches and future directions.

Authors:  Mark Laws; Ali Shaaban; Khondaker Miraz Rahman
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

10.  Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Xuan Yang; Ronald Domalaon; Yinfeng Lyu; George G Zhanel; Frank Schweizer
Journal:  J Clin Med       Date:  2018-06-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.